Billionaires and Trump Were Buying This Healthcare Stock

insidermonkey.com · 2026-10-19

Abbott Laboratories (NYSE:ABT) is one of the top 10 picks in President Trump’s latest stock portfolio. Trump bought $1 million to $5 million of Abbott in August.

TickrTrends take: Abbott Laboratories trades at a valuation that TickrTrends currently assesses as undervalued within the Healthcare sector, creating potential interest from investors seeking price-to-value opportunities. Recent buying activity by high-net-worth individuals and political figures may reflect confidence in the company's fundamentals, though valuation-focused investors should monitor whether such buying patterns sustain or whether the market reprices the stock relative to earnings and cash flow metrics. The combination of perceived undervaluation and notable investor interest suggests ABT warrants continued observation of its financial performance and market positioning within Healthcare.

Read the full story at insidermonkey.com →